9-14113076-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001190737.2(NFIB):c.1390A>G(p.Thr464Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000452 in 1,549,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001190737.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000429 AC: 6AN: 1397322Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 689176
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74274
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1390A>G (p.T464A) alteration is located in exon 10 (coding exon 10) of the NFIB gene. This alteration results from a A to G substitution at nucleotide position 1390, causing the threonine (T) at amino acid position 464 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at